BioSpace News Archive

10x Genomics (Nasdaq: TXG), a life sciences leader focused on mastering biology to advance human health, today announced it will report financial results for the first quarter 2023 after market close on Wednesday, May 3, 2023.

Oncocyte Corporation, a precision diagnostics company, announced a reduction in force involving approximately 20% of its workforce, which management believes will extend Oncocyte’s cash runway in 2024.

DBV Technologies, a clinical-stage biopharmaceutical company, held its Ordinary and Extraordinary General Meeting.

CTI BioPharma Corp. (Nasdaq: CTIC) today announced that the management team will participate in two upcoming investor conferences in April 2023.

Zealand Pharma A/S (Nasdaq Copenhagen: ZEAL) (CVR-no. 20045078,) a biotechnology company focused on the discovery and development of innovative peptide-based medicines, today announced that it will present an overview of the company at the 22nd Annual Needham Virtual Healthcare Conference.

Allegro Ophthalmics, LLC today announced that the Company has received agreement from the U.S. Food and Drug Administration (FDA) under a Special Protocol Assessment (SPA) for the design of its Phase 2b/3 clinical trial of risuteganib (Luminate®) for the treatment of intermediate, non-exudative age-related macular degeneration (dry AMD).

We are pleased to announce that Dr. Robert Nolan, spine surgeon, has joined the Auburn Orthopaedic Specialists practice which is affiliated with Auburn Community Hospital.

Company’s Novel “Dynamic Dimensional Detection” Array Technology Delivers Unprecedented Performance in Multiplexing, Turn-Around Time, Throughput and Cost Per Test

Vallon Pharmaceuticals, Inc., announced that its Special Meeting of Stockholders, scheduled for and convened on April 12, 2023, has been adjourned to provide the Company’s stockholders additional time to consider and vote FOR the proposals in the Proxy.

Impel Pharmaceuticals, a commercial-stage pharmaceutical company developing transformative therapies for people suffering from diseases with high unmet medical needs, announced the appointment of Darren Cline to the Board of Directors.